Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Agile Therapeutics (AGRX) PT Lowered to $5 at Cantor Fitzgerald
-
Pre-Open Movers 09/22: (ASND) (SVRA) (S) Higher; (VSAR) (ICPT) (FINL) Lower (more...)
-
Cantor Fitzgerald Assumes Agile Therapeutics (AGRX) at Overweight
-
Agile Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Agile Therapeutics (AGRX) Prices 5.33M Common Stock Offering at $3.75/Share
-
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
-
Agile Therapeutics (AGRX) Plans Offering of Common Stock
-
Agile Therapeutics Announces Proposed Offering of Common Stock
-
Agile Therapeutics (AGRX) PT Raised to $9 at Cantor Fitzgerald Following KOL Call on Twirla
-
Agile Therapeutics (AGRX): NDA Success Unclear but Possible - Cantor Fitzgerald
-
Agile Therapeutics to Present at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
-
Agile Therapeutics (AGRX) Prices 5.5M Common Stock Offering at $6.35/Share
-
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
-
Agile Therapeutics (AGRX) Plans $30M Common Stock Offering
-
Agile Therapeutics Announces Proposed Offering of Common Stock
-
Cantor Fitzgerald Starts Agile Therapeutics (AGRX) at Buy
-
Agile Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
-
Cantor Fitzgerald Starts Agile Therapeutics (AGRX) at Buy
-
Agile Therapeutics (AGRX) IPO Opens 8% Lower
-
Agile Therapeutics (AGRX) Prices IPO at $6

